Published in Neuroscience on January 01, 1999
Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory. Philos Trans R Soc Lond B Biol Sci (2003) 2.34
A neoHebbian framework for episodic memory; role of dopamine-dependent late LTP. Trends Neurosci (2011) 2.04
The dendritic branch is the preferred integrative unit for protein synthesis-dependent LTP. Neuron (2011) 1.75
How long will long-term potentiation last? Philos Trans R Soc Lond B Biol Sci (2003) 1.63
Dopaminergic modulation of the persistence of one-trial hippocampus-dependent memory. Learn Mem (2006) 1.35
Requirement of beta-adrenergic receptor activation and protein synthesis for LTP-reinforcement by novelty in rat dentate gyrus. J Physiol (2003) 1.20
The synaptic plasticity and memory hypothesis: encoding, storage and persistence. Philos Trans R Soc Lond B Biol Sci (2013) 1.13
Trial outcome and associative learning signals in the monkey hippocampus. Neuron (2009) 1.10
Dopaminergic modulation of the hippocampal neuropil proteome identified by bioorthogonal noncanonical amino acid tagging (BONCAT). Proteomics (2012) 1.05
Dopaminergic modulation of auditory cortex-dependent memory consolidation through mTOR. Cereb Cortex (2008) 1.05
Dopamine D1/D5 receptors mediate informational saliency that promotes persistent hippocampal long-term plasticity. Cereb Cortex (2012) 1.02
Regulation of AMPA receptor trafficking in the nucleus accumbens by dopamine and cocaine. Neurotox Res (2010) 1.01
Viagra for your synapses: Enhancement of hippocampal long-term potentiation by activation of beta-adrenergic receptors. Cell Signal (2009) 0.99
D1/5 receptor-mediated enhancement of LTP requires PKA, Src family kinases, and NR2B-containing NMDARs. Neuropharmacology (2008) 0.97
The role of the direct perforant path input to the CA1 subregion of the dorsal hippocampus in memory retention and retrieval. Hippocampus (2007) 0.94
Relationship of hippocampal theta and gamma oscillations to potentiation of synaptic transmission. Front Neurosci (2008) 0.90
Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice. Biol Psychiatry (2012) 0.90
Learning-facilitated long-term depression and long-term potentiation at mossy fiber-CA3 synapses requires activation of β-adrenergic receptors. Front Integr Neurosci (2012) 0.89
Different requirements for action potentials in the induction of different forms of long-term potentiation. J Physiol (2008) 0.88
Hippocampal-prefrontal circuit and disrupted functional connectivity in psychiatric and neurodegenerative disorders. Biomed Res Int (2015) 0.87
Synaptic tagging and capture in the living rat. Nat Commun (2012) 0.85
Dopamine transporter blockade increases LTP in the CA1 region of the rat hippocampus via activation of the D3 dopamine receptor. Learn Mem (2006) 0.84
Synaptic depression in the CA1 region of freely behaving mice is highly dependent on afferent stimulation parameters. Front Integr Neurosci (2013) 0.84
Dopamine Regulates Aversive Contextual Learning and Associated In Vivo Synaptic Plasticity in the Hippocampus. Cell Rep (2016) 0.83
Protein kinase Mzeta is essential for the induction and maintenance of dopamine-induced long-term potentiation in apical CA1 dendrites. Learn Mem (2010) 0.83
Dopamine Modulates Spike Timing-Dependent Plasticity and Action Potential Properties in CA1 Pyramidal Neurons of Acute Rat Hippocampal Slices. Front Synaptic Neurosci (2011) 0.83
Dopamine regulates intrinsic excitability thereby gating successful induction of spike timing-dependent plasticity in CA1 of the hippocampus. Front Neurosci (2013) 0.83
Protein Kinase A and Anxiety-Related Behaviors: A Mini-Review. Front Endocrinol (Lausanne) (2016) 0.82
β-Adrenergic receptor signaling and modulation of long-term potentiation in the mammalian hippocampus. Learn Mem (2015) 0.81
β-Adrenergic Control of Hippocampal Function: Subserving the Choreography of Synaptic Information Storage and Memory. Cereb Cortex (2016) 0.80
Cocaine enhancement of long-term potentiation in the CA1 region of rat hippocampus: lamina-specific mechanisms of action. Synapse (2010) 0.79
Possible contributions of a novel form of synaptic plasticity in Aplysia to reward, memory, and their dysfunctions in mammalian brain. Learn Mem (2013) 0.79
Septo-hippocampo-septal loop and memory formation. Basic Clin Neurosci (2013) 0.78
Reduced threshold for induction of LTP by activation of dopamine D1/D5 receptors at hippocampal CA1-subiculum synapses. PLoS One (2013) 0.78
A structure-function mechanism for schizophrenia. Front Psychiatry (2012) 0.76
Blocking Dopaminergic Signaling Soon after Learning Impairs Memory Consolidation in Guinea Pigs. PLoS One (2015) 0.75
β-adrenergic signaling broadly contributes to LTP induction. PLoS Comput Biol (2017) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Equating health status measures with item response theory: illustrations with functional status items. Med Care (2000) 3.98
Review: history of the amyloid fibril. J Struct Biol (2000) 3.49
Acute infectious arthritis. A review of patients with nongonococcal joint infections (with emphasis on therapy and prognosis). Am J Med (1976) 3.07
Amyloidosis. N Engl J Med (1967) 2.97
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med (1999) 2.78
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience (1997) 2.56
Long-term depression in hippocampus. Annu Rev Neurosci (1996) 2.42
Long-term potentiation in the hippocampus using depolarizing current pulses as the conditioning stimulus to single volley synaptic potentials. J Neurosci (1987) 2.30
Acute arthritis caused by gram-negative bacilli: a clinical characterization. Medicine (Baltimore) (1974) 2.25
High-resolution electron microscopic analysis of the amyloid fibril. J Cell Biol (1967) 2.16
The pathogenesis and biochemistry of amyloidosis. J Pathol (1987) 2.15
Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol (1979) 2.08
Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res (1997) 2.08
Treatment of septic arthritis: comparison of needle aspiration and surgery as initial modes of joint drainage. Arthritis Rheum (1975) 2.03
Blockage of amyloid induction by colchicine in an animal model. J Exp Med (1974) 1.96
Studies of immune deposits in synovial membranes and corresponding synovial fluids. J Lab Clin Med (1968) 1.90
Metabotropic glutamate receptors trigger homosynaptic protein synthesis to prolong long-term potentiation. J Neurosci (2000) 1.89
Synovial membrane histopathology in the differential diagnosis of rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus, infectious arthritis and degenerative joint disease. Medicine (Baltimore) (1978) 1.83
Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev (1995) 1.81
A clinical analysis of the course and prognosis of forty-two patients with amyloidosis. Am J Med (1968) 1.80
Sensitivity, specificity, and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis. Arthritis Rheum (1989) 1.76
Criteria for the classification of systemic lupus erythematosus--status 1972. Arthritis Rheum (1973) 1.71
Stabilization of Thylakoid Membranes by Spermine during Stress-induced Senescence of Barley Leaf Discs. Plant Physiol (1979) 1.70
Plasma protein constituents of amyloid fibrils. J Immunol (1967) 1.70
Neuroprotective effects of adenosine. Trends Pharmacol Sci (1988) 1.69
Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab Invest (1990) 1.69
Characterization of the amyloid fibril as a cross-beta protein. Proc Soc Exp Biol Med (1969) 1.66
Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol (1998) 1.66
Inflammatory synovitis in degenerative joint disease. J Rheumatol (1982) 1.65
The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev (1998) 1.64
Amyloidosis (concluded). N Engl J Med (1967) 1.64
Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med (1994) 1.63
Regional hippocampal alteration associated with cognitive deficit following experimental brain injury: a systems, network and cellular evaluation. Neuroscience (2005) 1.61
The constitution and genesis of amyloid. Int Rev Exp Pathol (1965) 1.61
Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998. Part 1. Amyloid (1999) 1.59
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience (2000) 1.55
Localized amyloidosis of the lower respiratory tract. Am Rev Respir Dis (1978) 1.54
Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases. Arthritis Rheum (1979) 1.53
The light and electron microscopic autoradiographic demonstration of local amyloid formation in spleen explants. Am J Pathol (1965) 1.52
Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med (1996) 1.49
Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry (1985) 1.49
Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol (1987) 1.49
"A" protein of amyloidosis. Isolation of a cross-reacting component from serum by affinity chromatography. Arthritis Rheum (1975) 1.46
The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration. Arthritis Rheum (1985) 1.46
The role of immediate early genes in the stabilization of long-term potentiation. Mol Neurobiol (1991) 1.41
P-component (pentagonal unit) of amyloid: isolation, characterization, and sequence analysis. J Lab Clin Med (1974) 1.40
A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun (1992) 1.39
Isolation and identification by sequence analysis of experimentally induced guinea pig amyloid fibrils. J Exp Med (1974) 1.39
Hereditary amyloidosis. Arthritis Rheum (1971) 1.38
Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol (1984) 1.38
Amyloid proteins, precursors, mediator, and enhancer. Lab Invest (1983) 1.38
Maintenance of long-term potentiation in rat dentate gyrus requires protein synthesis but not messenger RNA synthesis immediately post-tetanization. Neuroscience (1989) 1.37
Survival of patients with primary (AL) amyloidosis. Colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973). Am J Med (1987) 1.37
In vitro formation of amyloid fibrils from intact beta 2-microglobulin. Biochem Biophys Res Commun (1985) 1.37
Senile cerebral amyloid. Prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle, and in the microangiopathic lesion. Am J Pathol (1982) 1.36
Murine amyloid protein AA in casein-induced experimental amyloidosis. Lab Invest (1977) 1.35
Animal model for human disease: spontaneous and induced amyloidosis. Am J Pathol (1972) 1.34
Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther (2001) 1.34
The role of interleukin 1 in acute phase serum amyloid A (SAA) and serum amyloid P (SAP) biosynthesis. Ann N Y Acad Sci (1982) 1.33
The prealbumin nature of the amyloid protein in familial amyloid polyneuropathy (FAP)-swedish variety. Biochem Biophys Res Commun (1981) 1.32
Treatment of Wegener's granulomatosis with immunosuppressive agents. Description of renal ultrastructure. Arch Intern Med (1970) 1.29
The role of mucopolysaccharides in vesicle architecture and endothelial transport. An electron microscope study of myocardial blood vessels. J Cell Biol (1972) 1.29
Digoxin sensitivity in amyloid cardiomyopathy. Circulation (1981) 1.28
Total and capillary fingertip blood flow in Raynaud's phenomenon. N Engl J Med (1971) 1.27
Correlations between immediate early gene induction and the persistence of long-term potentiation. Neuroscience (1993) 1.26
Arthritis associated with gonorrhoea. Ann Rheum Dis (1968) 1.26
Asymmetric relationships between homosynaptic long-term potentiation and heterosynaptic long-term depression. Nature (1983) 1.24
Mechanisms underlying the inability to induce area CA1 LTP in the mouse after traumatic brain injury. Hippocampus (2006) 1.24
CREB phosphorylation promotes nerve cell survival. J Neurochem (1999) 1.24
Priming of associative long-term depression in the dentate gyrus by theta frequency synaptic activity. Neuron (1992) 1.23
The degradation of serum amyloid A protein by activated polymorphonuclear leucocytes: participation of granulocytic elastase. Immunology (1982) 1.23
Fine structural analysis of rabbit synovial cells. I. The normal synovium and changes in organ culture. Arthritis Rheum (1973) 1.23
An analysis of the close relationship of lysosomes to early deposits of amyloid. Ultrastructural evidence in experimental mouse amyloidosis. Am J Pathol (1973) 1.22
Heterosynaptic metaplasticity in the hippocampus in vivo: a BCM-like modifiable threshold for LTP. Proc Natl Acad Sci U S A (2001) 1.22
Bidirectional modification of CA1 synapses in the adult hippocampus in vivo. Nature (1996) 1.22
Bleeding manifestations in 100 patients with amyloidosis. JAMA (1983) 1.21
Hippocampal long-term potentiation is induced by pairing single afferent volleys with intracellularly injected depolarizing current pulses. Acta Physiol Scand (1986) 1.21
Tuberculous arthritis: A report of two cases with review of biopsy and synovial fluid findings. Am J Med (1976) 1.21
The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain. Neuroscience (2005) 1.21
Suppression of in vitro antibody response by a serum factor (SAA) in experimentally induced amyloidosis. J Exp Med (1975) 1.21
Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Brain Res Mol Brain Res (1995) 1.20
The P-component of amyloid of human islets of langerhans. Scand J Immunol (1975) 1.20
Solubility characteristics of isolated amyloid fibrils. Biochim Biophys Acta (1965) 1.20
Specific proteolysis of the NR2 subunit at multiple sites by calpain. J Neurochem (2001) 1.20
Amyloidosis: an expression of immunological tolerance? Lancet (1970) 1.20
Structure of amyloid fibrils after negative staining and high-resolution electron microscopy. Nature (1965) 1.17
Intralysosomal formation of amyloid fibrils. Am J Pathol (1975) 1.17
Detailed behavioral analysis of water maze acquisition under APV or CNQX: contribution of sensorimotor disturbances to drug-induced acquisition deficits. Behav Neurosci (1996) 1.17
The association of amyloid P-component (AP) with the amyloid fibril: an updated method for amyloid fibril protein isolation. Prep Biochem (1982) 1.15
Patterns of pulmonary involvement in systemic amyloidosis. Chest (1978) 1.15
Facilitation of long-term potentiation by prior activation of metabotropic glutamate receptors. J Neurophysiol (1996) 1.15
Herniation of mitral leaflets in the Ehlers-Danlos syndrome. Am J Cardiol (1975) 1.14
Localized amyloidosis of the head and neck and upper aerodigestive and lower respiratory tracts. Ann Otol Rhinol Laryngol (1984) 1.14
Antigenic determinants in amyloid deposits. Nature (1970) 1.13
Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system. Prog Neurobiol (1999) 1.13
Amyloidosis. N Engl J Med (1967) 1.12
Generalized amyloid in a family of Swedish origin. A study of 426 family members in seven generations of a new kinship with neuropathy, nephropathy, and central nervous system involvement. Ann Intern Med (1977) 1.11
Immunohistochemical evidence for the lack of amyloid P component in some intracerebral amyloids. Lab Invest (1982) 1.11
Renal transplantation in two cases of amyloidosis. Lancet (1971) 1.11